{
  "id": 172284,
  "name": "AMAZON.COM (FRA PILLPACK AN AMAZON COMPANY)",
  "slug": "amazon-com-fra-pillpack-an-amazon-company",
  "state": "NH",
  "description": "Pharmacy",
  "totalSpending": 1350000,
  "filings": 27,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 150000
    },
    {
      "year": 2019,
      "income": 200000
    },
    {
      "year": 2020,
      "income": 200000
    },
    {
      "year": 2021,
      "income": 200000
    },
    {
      "year": 2022,
      "income": 200000
    },
    {
      "year": 2023,
      "income": 200000
    },
    {
      "year": 2024,
      "income": 150000
    },
    {
      "year": 2025,
      "income": 50000
    }
  ],
  "firms": [
    "CARD & ASSOCIATES, LLC"
  ],
  "lobbyists": [
    "A CARD",
    "ADAM BORDES"
  ],
  "issues": [
    "PHA",
    null
  ],
  "sampleDescriptions": [
    "Educate Members on pharmacy contracting with pharmacy benefit managers\nH.R. 1316 Prescription Drug Price Transparency Act\nS. 637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act\nCMS-4182-P Technical Changes Defining Mail Order Pharmacy and Retail Pharmacy Comments-Final Regulations\nS. 2554 Patient Right to Know Drug Prices Act",
    "Educate Members on pharmacy contracting with pharmacy benefit managers\nMonitoring legislation:\nH.R. 1316 Prescription Drug Price Transparency Act\nS. 637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act\nS. 2554 Patient Right to Know Drug Prices Act",
    "Educate Members on pharmacy contracting with pharmacy benefit managers\nMonitoring legislation on drug price transparency and market access issues",
    "Educate Members on pharmacy contracting with pharmacy benefit managers\nMonitoring legislation on drug price transparency and market access issues\nS 1895 Lower Healthcare Costs Act\nHR 2296 Fair Accountability and Innovative Research Drug Pricing Act\nHR 2376 Prescription Pricing for the People Act",
    "Educate Members on pharmacy contracting with pharmacy benefit managers\nMonitoring legislation on drug price transparency and market access issues including legislative proposals related to drug pricing\nS 1895 Lower Healthcare Costs Act\nHR 2296 Fair Accountability and Innovative Research Drug Pricing Act\nHR 2376 Prescription Pricing for the People Act",
    "Monitoring legislation on drug price transparency and market access issues including legislative proposals related to drug pricing\nMonitoring federal appropriations (HR 133)",
    "Monitoring legislation on drug price transparency and market access issues including legislative proposals related to drug pricing\nMonitoring federal appropriations (HR 1319)",
    "Monitoring legislation on drug price transparency and market access issues including legislative proposals related to drug pricing\nMonitoring federal appropriations for FY 2022\nAccess to telemedicine",
    "Monitoring legislation on drug price transparency and market access issues including legislative proposals related to drug pricing Monitoring federal appropriations for FY 2022 Access to telemedicine",
    "Monitoring legislation on drug price transparency and market access issues including legislative proposals related to drug pricing Monitoring federal appropriations for FY 2023 Access to telehealth Healthcare Extenders",
    "Monitor legislation on drug price transparency and market access issues including legislative proposals related to drug pricing Monitor FY 2025 Appropriations Support access to telehealth Monitor and engage on EU digital regulatory policies Monitor international trade issues",
    "Monitor legislation on drug price transparency and market access issues including legislative proposals related to drug pricing Monitor FY 2025 Appropriations Support access to telehealth Monitor and engage on EU & Canadian digital regulatory policies Monitor international trade issues",
    "Monitor legislation on drug price transparency and market access issues including legislative proposals related to drug pricing Monitor FY 2025 Appropriations Support access to telehealth Monitor and engage on EU & Canadian digital regulatory policies Monitor international trade issues Monitor H.R. 10545"
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": -67,
  "trajectory": "declining",
  "yearsActive": 8,
  "avgAnnualSpending": 168750,
  "peakYear": 2019,
  "lobbyistCount": 2,
  "firmCount": 1,
  "issueCount": 1
}